Cappella, an Ireland-based developer of medical devices, has raised €10.5m ($14.7m) in its series D round from a consortium including Japanese bank Mitsui’s venturing division.
Mitsui & Company Venture Partners, which separated from Japanese joint venture partner Sumitomo in May, along with venture capital (VC) firms Polytechnos Partners, ACT Venture Capital, Fountain Healthcare Partners and venture debt provider Kreos Capital and Silicon Valley Bank (SVB) made up the consortium.
Phil Cox, head of UK, Europe and Israel at SVB, said: "Silicon Valley Bank has been dedicated to helping entrepreneurs succeed for nearly 30 years. We are delighted to be in a position to support Cappella with its continued growth as it expands its global network and product pipeline."
In June last year, Cappella raised $17.3m in its series C round from Mitsui and the three VCs to launch its Sideguard Sidebranch stent that holds arteries open and also hired Art Rosenthal as chief executive.